 |
PDBsum entry 2j0l
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.2.7.10.2
- non-specific protein-tyrosine kinase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
L-tyrosyl-[protein] + ATP = O-phospho-L-tyrosyl-[protein] + ADP + H+
|
 |
 |
 |
 |
 |
L-tyrosyl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-tyrosyl-[protein]
Bound ligand (Het Group name = )
matches with 81.25% similarity
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Cell
129:1177-1187
(2007)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structural basis for the autoinhibition of focal adhesion kinase.
|
|
D.Lietha,
X.Cai,
D.F.Ceccarelli,
Y.Li,
M.D.Schaller,
M.J.Eck.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Appropriate tyrosine kinase signaling depends on coordinated sequential coupling
of protein-protein interactions with catalytic activation. Focal adhesion kinase
(FAK) integrates signals from integrin and growth factor receptors to regulate
cellular responses including cell adhesion, migration, and survival. Here, we
describe crystal structures representing both autoinhibited and active states of
FAK. The inactive structure reveals a mechanism of inhibition in which the
N-terminal FERM domain directly binds the kinase domain, blocking access to the
catalytic cleft and protecting the FAK activation loop from Src phosphorylation.
Additionally, the FERM domain sequesters the Tyr397 autophosphorylation and Src
recruitment site, which lies in the linker connecting the FERM and kinase
domains. The active phosphorylated FAK kinase adopts a conformation that is
immune to FERM inhibition. Our biochemical and structural analysis shows how the
architecture of autoinhibited FAK orchestrates an activation sequence of FERM
domain displacement, linker autophosphorylation, Src recruitment, and full
catalytic activation.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Figure 1. Structure of Autoinhibited FAK (A) Domain
structure of FAK. Key tyrosine phosphorylation sites are
indicated. (B) Overall structure of autoinhibited FAK
including the FERM, linker, and kinase regions. In the
autoinhibited state, the FERM domain (blue ribbon
representation) binds the kinase domain (red), primarily through
an interaction between the FERM F2 lobe and the kinase
C-lobe. A section of the linker that contains the
autophosphorylation site Tyr397 (yellow) is located between the
FERM F1 lobe and the kinase N-lobe. The FERM domain also blocks
access to the active-site cleft and to the kinase activation
loop (A-loop, green). Disordered segments are indicated as
dashed lines. The staurosporine analog AFN941 is bound to the
active site of the kinase and is shown in stick representation.
(C) Sequence alignment of the FERM, linker, and kinase
regions of avian FAK (cFAK1), human FAK (hFAK1), and human Pyk2
(hPyk2). cFAK1 shares 94% sequence identity with hFAK1, and
hFAK1 shares 43% with hPyk2. Secondary structure elements are
indicated, and the sequence is shaded to correspond to the
colors in (B). Residues involved in the FERM F2 lobe/kinase
C-lobe interaction are indicated by an asterisk, and regulatory
tyrosines are colored magenta.
|
 |
Figure 2.
Figure 2. Structure of the Active Kinase Domain of FAK
(A) The structure of the FAK kinase domain phosphorylated by Src
is shown in ribbon representation (green) with the activation
loop in blue. The side chains of phosphotyrosines 576 and 577
and AMP-PNP, which is bound to the active site, are shown in
stick representation. A Mg^2+ ion at the active site is shown as
a yellow sphere. (B) Close-up view of the activation loop
with the side chains of pY576, pY577, R569, and R545 and the
main chains of A579 and S580 shown in stick representation. A
network of hydrogen bonds (orange dashed lines) involving the
phosphate group of pY577 stabilizes the conformation of the
activation loop. (C) Superposition of active and inactive
FAK kinases. The autoinhibited structure is shown with the FERM
domain as a surface representation (light blue), and the linker
and kinase domains are shown in a ribbon representation colored
yellow and red, respectively. The structure of the active kinase
domain (green ribbon and blue activation loop) is superimposed
based on the kinase C-lobes. The side chain of pY576 and the
main chain carbonyl of A579 in the active kinase (both residues
are shown in space filling representations) clash with the FERM
domain in the autoinhibited structure.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Cell Press:
Cell
(2007,
129,
1177-1187)
copyright 2007.
|
|
| |
Figures were
selected
by the author.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
H.J.Kung
(2011).
Targeting Tyrosine Kinases and Autophagy in Prostate Cancer.
|
| |
Horm Cancer,
2,
38-46.
|
 |
|
|
|
|
 |
P.J.Lupardus,
G.Skiniotis,
A.J.Rice,
C.Thomas,
S.Fischer,
T.Walz,
and
K.C.Garcia
(2011).
Structural snapshots of full-length Jak1, a transmembrane gp130/IL-6/IL-6Rα cytokine receptor complex, and the receptor-Jak1 holocomplex.
|
| |
Structure,
19,
45-55.
|
 |
|
|
|
|
 |
T.H.Chen,
P.C.Chan,
C.L.Chen,
and
H.C.Chen
(2011).
Phosphorylation of focal adhesion kinase on tyrosine 194 by Met leads to its activation through relief of autoinhibition.
|
| |
Oncogene,
30,
153-166.
|
 |
|
|
|
|
 |
W.F.Zambuzzi,
C.V.Ferreira,
J.M.Granjeiro,
and
H.Aoyama
(2011).
Biological behavior of pre-osteoblasts on natural hydroxyapatite: a study of signaling molecules from attachment to differentiation.
|
| |
J Biomed Mater Res A,
97,
193-200.
|
 |
|
|
|
|
 |
Y.L.Hsu,
L.Y.Wu,
M.F.Hou,
E.M.Tsai,
J.N.Lee,
H.L.Liang,
Y.J.Jong,
C.H.Hung,
and
P.L.Kuo
(2011).
Glabridin, an isoflavan from licorice root, inhibits migration, invasion and angiogenesis of MDA-MB-231 human breast adenocarcinoma cells by inhibiting focal adhesion kinase/Rho signaling pathway.
|
| |
Mol Nutr Food Res,
55,
318-327.
|
 |
|
|
|
|
 |
A.V.Karginov,
F.Ding,
P.Kota,
N.V.Dokholyan,
and
K.M.Hahn
(2010).
Engineered allosteric activation of kinases in living cells.
|
| |
Nat Biotechnol,
28,
743-747.
|
 |
|
|
|
|
 |
C.A.Lipinski,
and
J.C.Loftus
(2010).
Targeting Pyk2 for therapeutic intervention.
|
| |
Expert Opin Ther Targets,
14,
95.
|
 |
|
|
|
|
 |
C.B.McDonald,
K.L.Seldeen,
B.J.Deegan,
V.Bhat,
and
A.Farooq
(2010).
Assembly of the Sos1-Grb2-Gab1 ternary signaling complex is under allosteric control.
|
| |
Arch Biochem Biophys,
494,
216-225.
|
 |
|
|
|
|
 |
J.A.Bartos,
J.D.Ulrich,
H.Li,
M.A.Beazely,
Y.Chen,
J.F.Macdonald,
and
J.W.Hell
(2010).
Postsynaptic clustering and activation of Pyk2 by PSD-95.
|
| |
J Neurosci,
30,
449-463.
|
 |
|
|
|
|
 |
J.L.Guan
(2010).
Integrin signaling through FAK in the regulation of mammary stem cells and breast cancer.
|
| |
IUBMB Life,
62,
268-276.
|
 |
|
|
|
|
 |
J.T.Parsons,
A.R.Horwitz,
and
M.A.Schwartz
(2010).
Cell adhesion: integrating cytoskeletal dynamics and cellular tension.
|
| |
Nat Rev Mol Cell Biol,
11,
633-643.
|
 |
|
|
|
|
 |
J.Vomaske,
S.Varnum,
R.Melnychuk,
P.Smith,
L.Pasa-Tolic,
J.I.Shutthanandan,
and
D.N.Streblow
(2010).
HCMV pUS28 initiates pro-migratory signaling via activation of Pyk2 kinase.
|
| |
Herpesviridae,
1,
2.
|
 |
|
|
|
|
 |
J.Zhong,
A.Paul,
S.J.Kellie,
and
G.M.O'Neill
(2010).
Mesenchymal migration as a therapeutic target in glioblastoma.
|
| |
J Oncol,
2010,
430142.
|
 |
|
|
|
|
 |
L.Zhao,
Y.Ma,
J.Seemann,
and
L.J.Huang
(2010).
A regulating role of the JAK2 FERM domain in hyperactivation of JAK2(V617F).
|
| |
Biochem J,
426,
91-98.
|
 |
|
|
|
|
 |
M.C.Frame,
H.Patel,
B.Serrels,
D.Lietha,
and
M.J.Eck
(2010).
The FERM domain: organizing the structure and function of FAK.
|
| |
Nat Rev Mol Cell Biol,
11,
802-814.
|
 |
|
|
|
|
 |
O.A.Gani,
and
R.A.Engh
(2010).
Protein kinase inhibition of clinically important staurosporine analogues.
|
| |
Nat Prod Rep,
27,
489-498.
|
 |
|
|
|
|
 |
S.T.Lim,
N.L.Miller,
J.O.Nam,
X.L.Chen,
Y.Lim,
and
D.D.Schlaepfer
(2010).
Pyk2 inhibition of p53 as an adaptive and intrinsic mechanism facilitating cell proliferation and survival.
|
| |
J Biol Chem,
285,
1743-1753.
|
 |
|
|
|
|
 |
V.Prieto-Echagüe,
A.Gucwa,
B.P.Craddock,
D.A.Brown,
and
W.T.Miller
(2010).
Cancer-associated mutations activate the nonreceptor tyrosine kinase Ack1.
|
| |
J Biol Chem,
285,
10605-10615.
|
 |
|
|
|
|
 |
A.P.Gilmore,
T.W.Owens,
F.M.Foster,
and
J.Lindsay
(2009).
How adhesion signals reach a mitochondrial conclusion--ECM regulation of apoptosis.
|
| |
Curr Opin Cell Biol,
21,
654-661.
|
 |
|
|
|
|
 |
A.Tomar,
and
D.D.Schlaepfer
(2009).
Focal adhesion kinase: switching between GAPs and GEFs in the regulation of cell motility.
|
| |
Curr Opin Cell Biol,
21,
676-683.
|
 |
|
|
|
|
 |
A.Y.Park,
T.L.Shen,
S.Chien,
and
J.L.Guan
(2009).
Role of focal adhesion kinase Ser-732 phosphorylation in centrosome function during mitosis.
|
| |
J Biol Chem,
284,
9418-9425.
|
 |
|
|
|
|
 |
C.Brignatz,
M.P.Paronetto,
S.Opi,
M.Cappellari,
S.Audebert,
V.Feuillet,
G.Bismuth,
S.Roche,
S.T.Arold,
C.Sette,
and
Y.Collette
(2009).
Alternative splicing modulates autoinhibition and SH3 accessibility in the Src kinase Fyn.
|
| |
Mol Cell Biol,
29,
6438-6448.
|
 |
|
|
|
|
 |
D.S.Harburger,
and
D.A.Calderwood
(2009).
Integrin signalling at a glance.
|
| |
J Cell Sci,
122,
159-163.
|
 |
|
|
|
|
 |
D.Zheng,
E.Kurenova,
D.Ucar,
V.Golubovskaya,
A.Magis,
D.Ostrov,
W.G.Cance,
and
S.N.Hochwald
(2009).
Targeting of the protein interaction site between FAK and IGF-1R.
|
| |
Biochem Biophys Res Commun,
388,
301-305.
|
 |
|
|
|
|
 |
E.Ciccimaro,
S.K.Hanks,
K.H.Yu,
and
I.A.Blair
(2009).
Absolute quantification of phosphorylation on the kinase activation loop of cellular focal adhesion kinase by stable isotope dilution liquid chromatography/mass spectrometry.
|
| |
Anal Chem,
81,
3304-3313.
|
 |
|
|
|
|
 |
J.Chen,
Y.Lu,
S.Meng,
M.H.Han,
C.Lin,
and
X.Wang
(2009).
alpha- and gamma-Protocadherins negatively regulate PYK2.
|
| |
J Biol Chem,
284,
2880-2890.
|
 |
|
|
|
|
 |
J.Zhao,
and
J.L.Guan
(2009).
Signal transduction by focal adhesion kinase in cancer.
|
| |
Cancer Metastasis Rev,
28,
35-49.
|
 |
|
|
|
|
 |
K.S.Grossmann,
H.Wende,
F.E.Paul,
C.Cheret,
A.N.Garratt,
S.Zurborg,
K.Feinberg,
D.Besser,
H.Schulz,
E.Peles,
M.Selbach,
W.Birchmeier,
and
C.Birchmeier
(2009).
The tyrosine phosphatase Shp2 (PTPN11) directs Neuregulin-1/ErbB signaling throughout Schwann cell development.
|
| |
Proc Natl Acad Sci U S A,
106,
16704-16709.
|
 |
|
|
|
|
 |
M.Malakhova,
I.Kurinov,
K.Liu,
D.Zheng,
I.D'Angelo,
J.H.Shim,
V.Steinman,
A.M.Bode,
and
Z.Dong
(2009).
Structural diversity of the active N-terminal kinase domain of p90 ribosomal S6 kinase 2.
|
| |
PLoS One,
4,
e8044.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.Siamakpour-Reihani,
H.J.Argiros,
L.J.Wilmeth,
L.L.Haas,
T.A.Peterson,
D.L.Johnson,
C.B.Shuster,
and
B.A.Lyons
(2009).
The cell migration protein Grb7 associates with transcriptional regulator FHL2 in a Grb7 phosphorylation-dependent manner.
|
| |
J Mol Recognit,
22,
9.
|
 |
|
|
|
|
 |
V.Shani,
Y.Bromberg,
O.Sperling,
and
E.Zoref-Shani
(2009).
Involvement of Src Tyrosine Kinases (SFKs) and of Focal Adhesion Kinase (FAK) in the Injurious Mechanism in Rat Primary Neuronal Cultures Exposed to Chemical Ischemia.
|
| |
J Mol Neurosci,
37,
50-59.
|
 |
|
|
|
|
 |
Y.Shan,
L.Yu,
Y.Li,
Y.Pan,
Q.Zhang,
F.Wang,
J.Chen,
and
X.Zhu
(2009).
Nudel and FAK as antagonizing strength modulators of nascent adhesions through paxillin.
|
| |
PLoS Biol,
7,
e1000116.
|
 |
|
|
|
|
 |
Y.Wang,
L.Flores,
S.Lu,
H.Miao,
Y.S.Li,
and
S.Chien
(2009).
Shear Stress Regulates the Flk-1/Cbl/PI3K/NF-κB Pathway Via Actin and Tyrosine Kinases.
|
| |
Cell Mol Bioeng,
2,
341-350.
|
 |
|
|
|
|
 |
A.L.Berrier,
C.W.Jones,
and
S.E.LaFlamme
(2008).
Tac-beta1 inhibits FAK activation and Src signaling.
|
| |
Biochem Biophys Res Commun,
368,
62-67.
|
 |
|
|
|
|
 |
D.Lietha,
and
M.J.Eck
(2008).
Crystal structures of the FAK kinase in complex with TAE226 and related bis-anilino pyrimidine inhibitors reveal a helical DFG conformation.
|
| |
PLoS ONE,
3,
e3800.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
E.Goksoy,
Y.Q.Ma,
X.Wang,
X.Kong,
D.Perera,
E.F.Plow,
and
J.Qin
(2008).
Structural basis for the autoinhibition of talin in regulating integrin activation.
|
| |
Mol Cell,
31,
124-133.
|
 |
|
|
|
|
 |
E.J.Cram,
K.M.Fontanez,
and
J.E.Schwarzbauer
(2008).
Functional characterization of KIN-32, the Caenorhabditis elegans homolog of focal adhesion kinase.
|
| |
Dev Dyn,
237,
837-846.
|
 |
|
|
|
|
 |
H.Chen,
C.F.Xu,
J.Ma,
A.V.Eliseenkova,
W.Li,
P.M.Pollock,
N.Pitteloud,
W.T.Miller,
T.A.Neubert,
and
M.Mohammadi
(2008).
A crystallographic snapshot of tyrosine trans-phosphorylation in action.
|
| |
Proc Natl Acad Sci U S A,
105,
19660-19665.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.Funakoshi-Tago,
S.Pelletier,
H.Moritake,
E.Parganas,
and
J.N.Ihle
(2008).
Jak2 FERM domain interaction with the erythropoietin receptor regulates Jak2 kinase activity.
|
| |
Mol Cell Biol,
28,
1792-1801.
|
 |
|
|
|
|
 |
R.W.Tilghman,
and
J.T.Parsons
(2008).
Focal adhesion kinase as a regulator of cell tension in the progression of cancer.
|
| |
Semin Cancer Biol,
18,
45-52.
|
 |
|
|
|
|
 |
S.T.Lim,
D.Mikolon,
D.G.Stupack,
and
D.D.Schlaepfer
(2008).
FERM control of FAK function: implications for cancer therapy.
|
| |
Cell Cycle,
7,
2306-2314.
|
 |
|
|
|
|
 |
S.T.Lim,
X.L.Chen,
Y.Lim,
D.A.Hanson,
T.T.Vo,
K.Howerton,
N.Larocque,
S.J.Fisher,
D.D.Schlaepfer,
and
D.Ilic
(2008).
Nuclear FAK promotes cell proliferation and survival through FERM-enhanced p53 degradation.
|
| |
Mol Cell,
29,
9.
|
 |
|
|
|
|
 |
T.K.Lundgren,
A.Stenqvist,
R.P.Scott,
T.Pawson,
and
P.Ernfors
(2008).
Cell migration by a FRS2-adaptor dependent membrane relocation of ret receptors.
|
| |
J Cell Biochem,
104,
879-894.
|
 |
|
|
|
|
 |
V.Ossovskaya,
S.T.Lim,
N.Ota,
D.D.Schlaepfer,
and
D.Ilic
(2008).
FAK nuclear export signal sequences.
|
| |
FEBS Lett,
582,
2402-2406.
|
 |
|
|
|
|
 |
X.Cai,
D.Lietha,
D.F.Ceccarelli,
A.V.Karginov,
Z.Rajfur,
K.Jacobson,
K.M.Hahn,
M.J.Eck,
and
M.D.Schaller
(2008).
Spatial and temporal regulation of focal adhesion kinase activity in living cells.
|
| |
Mol Cell Biol,
28,
201-214.
|
 |
|
|
|
|
 |
B.Serrels,
A.Serrels,
V.G.Brunton,
M.Holt,
G.W.McLean,
C.H.Gray,
G.E.Jones,
and
M.C.Frame
(2007).
Focal adhesion kinase controls actin assembly via a FERM-mediated interaction with the Arp2/3 complex.
|
| |
Nat Cell Biol,
9,
1046-1056.
|
 |
|
|
|
|
 |
E.Rozengurt
(2007).
Mitogenic signaling pathways induced by G protein-coupled receptors.
|
| |
J Cell Physiol,
213,
589-602.
|
 |
|
|
|
|
 |
J.Kuriyan,
and
D.Eisenberg
(2007).
The origin of protein interactions and allostery in colocalization.
|
| |
Nature,
450,
983-990.
|
 |
|
|
|
|
 |
M.A.Arnaout,
S.L.Goodman,
and
J.P.Xiong
(2007).
Structure and mechanics of integrin-based cell adhesion.
|
| |
Curr Opin Cell Biol,
19,
495-507.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |